Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04329702 · ClinicalTrials.gov registry record · NA
Mobile Coping Skills Training to Improve Cardiorespiratory Failure Survivors' Psychological Distress
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT04329702: Completed NA study, sponsored by Duke University.
NCT04329702 is a NA study that has completed, run by Duke University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04329702, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This is a pilot randomized clinical trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is designed to test the acceptability, feasibility, and clinical impact of a coping skills training intervention (Blueprint) delivered via a mobile app. This trial will allow us to determine if new changes to intervention delivery, inclusion criteria, and other factors are successful. It will also inform the development of a next-step efficacy focused trial.
Primary Outcome
Depression and anxiety symptoms. Scores range from 0 (better) to 42 (worse)
Interventions
- BEHAVIORAL Coping skills training mobile app with call from CST therapist
- BEHAVIORAL Coping skills training mobile app only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-12-03 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT04329702 record still lists
NCT04329702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Coping skills training mobile app with call from CST therapist is the first listed.
NCT04329702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04329702 about?
NCT04329702 is a clinical study titled "Mobile Coping Skills Training to Improve Cardiorespiratory Failure Survivors' Psychological Distress". This is a pilot randomized clinical trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is designed to test the acceptability, feasibility, and clinical impact of a coping skills training intervention (Blueprint) delivered via a mobile app. This t...
What is the current status of trial NCT04329702?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-12-03. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04329702?
The interventions under investigation include: Coping skills training mobile app with call from CST therapist (BEHAVIORAL), Coping skills training mobile app only (BEHAVIORAL).
Who is sponsoring clinical trial NCT04329702?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04329702's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI